Overview
Portfolio
More
Evidity
Provides growth capital to late-stage private companies with commercialized medical devices, in vitro diagnostics, and digital health solutions.
Portfolio
7+
Employees
3+
Founded
N/A
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedSources
Evidity
Provides growth capital to late-stage private companies with commercialized medical devices, in vitro diagnostics, and digital health solutions.
Portfolio
7+
Employees
3+
Founded
N/A
AUM
N/A
Showing 5 of 5 matched portfolio companies
Augmedics provides augmented reality surgical navigation solutions specifically designed for spine surgery, allowing surgeons to visualize patient anatomy in 3D without diverting their attention from the surgical field. This technology enhances accuracy and efficiency in pedicle screw placement while minimizing radiation exposure during procedures.
Funding: $82.5M
Rough estimate of the amount of funding raised
Funding: $82.5M
Rough estimate of the amount of funding raised
GT Medical Technologies offers GammaTile Therapy, a surgically targeted radiation treatment for patients with operable brain tumors, which is placed at the time of tumor resection. This technology minimizes radiation exposure to healthy tissue, reduces side effects, and ensures 100% treatment compliance, ultimately delaying tumor recurrence and potentially extending patient survival.
Funding: $110.2M
Rough estimate of the amount of funding raised
Funding: $110.2M
Rough estimate of the amount of funding raised
Magnolia Medical has developed the Steripath Initial Specimen Diversion Device, a pre-assembled and sterile blood-collection system that diverts the initial contaminated blood to reduce false-positive results in blood cultures. This technology addresses the issue of blood culture contamination, leading to improved diagnostic accuracy for sepsis testing and significant reductions in unnecessary antibiotic use and hospital costs.
Funding: $46.0M
Rough estimate of the amount of funding raised
Funding: $46.0M
Rough estimate of the amount of funding raised
Sonde Health utilizes a vocal biomarker platform that analyzes voice data through machine learning to assess mental, cognitive, and respiratory health. This technology enables early detection of health issues, enhances user engagement, and supports proactive health management.
A blockchain-based platform that enhances fan engagement in esports by enabling secure, transparent interactions between fans, teams, and sponsors. It addresses the challenge of limited direct fan participation and monetization opportunities in the esports ecosystem. By leveraging decentralized technology, it fosters deeper connections and new revenue streams for all stakeholders.
Showing 2 of 2 unmatched portfolio companies